Secondary outcome: CLASI · patients with cutaneous disease in systemic lupus erythematosus
1 finding from 1 review
Secondary outcome: Dermatology Quality of Life measure · patients with cutaneous disease in systemic lupus erythematosus
1 finding from 1 review
Adverse events: severe · patients with cutaneous disease in systemic lupus erythematosus
Oral hydroxychloroquine showed no clear difference in adverse events: severe compared with placebo (moderate certainty).
1 finding from 1 review
Minor adverse events · patients with cutaneous disease in systemic lupus erythematosus
Oral hydroxychloroquine showed no clear difference in adverse events: minor compared with placebo (moderate certainty).
1 finding from 1 review
Complete response · patients with cutaneous disease in systemic lupus erythematosus
1 finding from 1 review
Primary outcome: partial clinical response · patients with cutaneous disease in systemic lupus erythematosus
Oral hydroxychloroquine showed no clear difference in primary outcome: partial clinical response compared with placebo (low certainty).
1 finding from 1 review
Length of hospital stay · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in dense red cells in sickle cell disease · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Effects of K‐Cl cotransport red cell K+ and Mg2+ content (RBC magnesium) mM/kg Hb · people with sickle cell disease
1 finding from 1 review
Adverse events: diarrhoea and headache · people with sickle cell disease
1 finding from 1 review
Adverse events: including serious adverse events, vaso‐occlusive crisis, gastrointestinal disorder, headache or migraine, upper respiratory tract infection, rash · people with sickle cell disease
1 finding from 1 review
Change in frequency of vaso‐occlusive painful crises (as measured by pain diary days with significant pain) · people with sickle cell disease
1 finding from 1 review
Quality of life · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Objective measures of sleep · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another location
1 finding from 1 review
Subjective sleep quality or quantity · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another location
1 finding from 1 review
Participant or parent satisfaction · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another location
1 finding from 1 review
Cost‐effectiveness · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another location
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Delirium incidence or delirium‐free days at hospital discharge · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another location
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of mechanical ventilation · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another location
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another location
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found